Abstract Details
|
Michael Hoffmann, MD, FCP, FAHA, FAAN
(University of Central Florida)
PRESENTER |
No disclosure on file |
| Fabian H. Rossi, MD | Dr. Rossi has nothing to disclose. |
| Ramon L. Rodriguez Cruz, MD, FAAN (Neurology One) | The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez has received research support from Cerevance. The institution of Dr. Rodriguez has received research support from Neuraly. The institution of Dr. Rodriguez has received research support from Impax. The institution of Dr. Rodriguez has received research support from Teva. The institution of Dr. Rodriguez has received research support from Neurocrine. Dr. Rodriguez has received publishing royalties from a publication relating to health care. |